Your Complete Guide to Global Clinical Research and GCP Compliance
How to Design Recruitment & Retention Plan That Aligns With GCP, ICH and Regulatory Guidance How to Design Recruitment & Retention Plan That Aligns With GCP, ICH and Regulatory Guidance Designing an effective recruitment and retention plan is a crucial element in the success of clinical trials, particularly in specialized areas such as prostate cancer…
Recruitment & Retention Plan in Practice: Step-by-Step Guide for Sponsors, CROs and Sites Recruitment & Retention Plan in Practice: Step-by-Step Guide for Sponsors, CROs and Sites The successful execution of clinical trials is contingent upon effective recruitment and retention strategies tailored to the specific needs of the target population. In this guide, we outline the…
Quality Control and Peer Review Processes for High-Stakes Safety Management Plan & Unblinding Procedures Quality Control and Peer Review Processes for High-Stakes Safety Management Plan & Unblinding Procedures In the context of clinical trials, particularly within organizations like Sanofi, maintaining rigorous quality control and robust peer review processes is imperative for ensuring the effectiveness of…
Safety Management Plan & Unblinding Procedures for Oncology, Rare Disease and High-Risk Therapeutic Areas Safety Management Plan & Unblinding Procedures for Oncology, Rare Disease and High-Risk Therapeutic Areas In the realm of clinical studies, particularly in oncology, rare diseases, and high-risk therapeutic areas, the integrity of safety management is paramount. A robust safety management plan…
Vendor and Partner Oversight Considerations Related to Safety Management Plan & Unblinding Procedures Vendor and Partner Oversight Considerations Related to Safety Management Plan & Unblinding Procedures In the evolving landscape of clinical trials, particularly in the context of global studies such as world wide clinical trials, the effective oversight of vendors and partners has become…
Metrics and KPIs to Monitor the Quality and Timeliness of Safety Management Plan & Unblinding Procedures In clinical trial centers, it is essential to maintain a rigorous approach to safety management and unblinding procedures. The complexities surrounding these processes require a clear understanding of metrics and key performance indicators (KPIs) that demonstrate compliance while upholding…
Case Studies: Safety Management Plan & Unblinding Procedures That Improved Approvals and Inspection Outcomes Case Studies: Safety Management Plan & Unblinding Procedures That Improved Approvals and Inspection Outcomes In the realm of clinical trials, the effective management of safety and unblinding procedures is paramount to ensuring not only regulatory compliance but also the integrity of…
Common Deficiencies in Safety Management Plan & Unblinding Procedures Highlighted in FDA, EMA and MHRA Inspections Common Deficiencies in Safety Management Plan & Unblinding Procedures Highlighted in FDA, EMA and MHRA Inspections Introduction to Safety Management Plans in Clinical Trials A Safety Management Plan (SMP) is essential for the successful conduct of clinical trials. It…
Aligning Safety Management Plan & Unblinding Procedures With Protocol, SAP and Risk Management Frameworks Aligning Safety Management Plan & Unblinding Procedures With Protocol, SAP and Risk Management Frameworks The alignment of the Safety Management Plan (SMP) and unblinding procedures with the study protocol, Statistical Analysis Plan (SAP), and overall risk management frameworks is crucial in…
Digital-First Safety Management Plan & Unblinding Procedures Strategies for Complex and Decentralized Trials Digital-First Safety Management Plan & Unblinding Procedures Strategies for Complex and Decentralized Trials In the evolving landscape of clinical trials, particularly within the settings of complex and decentralized studies, the need for robust safety management plans and efficient unblinding procedures cannot be…